Clinical Trial Management Systems (CTMS)

World Market Report

MCP-6222

EXECUTIVE ENGAGEMENTS

POOL

22039
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1984
Interactions with Platform & by Email

PARTICIPANTS

441
Unique # Participated

VALIDATIONS

96
Responses Validated*

COMPANIES

71
Responses Validated*
* Login for a full stack data experience

DATE

OCT 2022

TABLES

122

PAGES

208

EDITION

15

PRICE

USD 5600

CODE

MCP-6222


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Amid the COVID-19 crisis, the global market for Clinical Trial Management Systems (CTMS) estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$2.6 Billion by 2027, growing at aCAGR of 14.6% over the period 2020-2027. Enterprise-Wide CTMS, one of the segments analyzed in the report, is projected to record 15.2% CAGR and reach US$1.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the On-Site CTMS segment is readjusted to a revised 13.3% CAGR for the next 7-year period.
The Clinical Trial Management Systems (CTMS) market in the U.S. is estimated at US$293.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$451.5 Million by the year 2027 trailing a CAGR of 14% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13% and 12.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.

SELECT PLAYERS

ArisGlobal LLC; BioClinica Inc.; Bio-Optronics Inc.; DSG Inc.; eResearch Technology Inc.; IBM Watson Health; Medidata Solutions; MedNet Solutions; Nextrials Inc.; Oracle Corp.; PAREXEL International Corp.; Trial By Fire Solutions LLC; Veeva Systems Inc.

SEGMENTS

» Deployment (Enterprise-Wide CTMS, On-Site CTMS) » Delivery Mode (Web-Based (On-Demand), Licensed Enterprise (On-Premise), Cloud (SaaS)) » End-Use (Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies, Other End-Uses)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Clinical Trial Management Systems (CTMS) Gain Ground
Recent Market Activity
Benefits Offered by CTMS
Global Market Overview
Clinical Trial Management Systems Market to Post Explosive Growth
Web-based Systems Dominate, Cloud-Based to Witness Fastest Growth
Key Players in the CTMS Market
Developed Countries Rule the Market
Pharmaceutical Firms and CROs to Drive Adoption Rate
Noteworthy Transformations in the Global Clinical Trial Sector
Clinical Trial Management Systems (CTMS) – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Clinical Trial Globalization Surges Demand for CTMS
2. FOCUS ON SELECT PLAYERS
ArisGlobal, LLC (USA)
BioClinica, Inc. (USA)
Bio-Optronics, Inc. (USA)
DSG, Inc. (USA)
eResearch Technology, Inc. (USA)
IBM Watson Health (USA)
MedNet Solutions (USA)
Medidata Solutions (USA)
Nextrials, Inc. (USA)
Oracle Corp. (USA)
PAREXEL International Corp. (USA)
Trial By Fire Solutions, LLC (USA)
Veeva Systems, Inc. (USA)
Winchester Business Systems (USA)
3. MARKET TRENDS & DRIVERS
Surging Global Population Offers Increased Growth Opportunities
Increased Spend on R&D - An Important Growth Driver
CROs - The Targeted Customers for CTMS
Outsourcing of R&D Projects to Propel CRO Market, Drives CTMS Demand
CROs Adept with New Technologies to See More Business in Future
Rise in Clinical Trial Complexities Propels CTMS Demand
Pharmaceutical & Biopharmaceutical Trends to Support CTMS Demand
Adoption of Digital Technologies Gains Pace
Clinical Trial Operators Demand Efficient Data Management Platforms
DLB System’s Solution with Data Management Tools
Systems Integration Becomes Imperative
Technological Innovations Drive Market Growth
MC10 Introduces BioStampRC System to Capture Clinical Trial Data
UF Health Cancer Center Unveils OnCore® Clinical Trials Management System
UAB Unveils Innovative Technology to Streamline Clinical Trial Management Solution
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Licensed Enterprise (On-Premise) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Licensed Enterprise (On-Premise) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Licensed Enterprise (On-Premise) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Enterprise-Wide CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Enterprise-Wide CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Enterprise-Wide CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for On-Site CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for On-Site CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for On-Site CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Web-Based (On-demand) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Web-Based (On-demand) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Web-Based (On-demand) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Cloud (SaaS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cloud (SaaS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cloud (SaaS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Large Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Large Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Large Pharma-Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Medical Device Manufacturers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
World Clinical Trial Management Systems (CTMS) Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
UNITED STATES
Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027
JAPAN
Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027
CHINA
Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027
EUROPE
Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027
FRANCE
Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027
GERMANY
Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027
UNITED KINGDOM
Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2012, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2012, 2021 & 2027
Rest of World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com